Is acetate a major end-product of colonic fermentation that supports butyrate production?

Acetate serves a dual role in human health as both a primary metabolic output of fiber fermentation and a critical building block for the synthesis of other beneficial metabolites.

Clinical and metabolic significance

• Acetate is the most abundant short-chain fatty acid (SCFA) in the human colon, typically comprising 60% to 75% of the total SCFA pool.
• In healthy individuals, the molar ratio of the three main SCFAs—acetate, propionate, and butyrate—remains relatively stable at approximately 60:20:20, regardless of specific dietary fiber intake.
• The production of acetate is vital for systemic health; while much of it is used locally in the gut, significant amounts enter the bloodstream where it can influence appetite regulation and lipid metabolism.

Mechanistic pathways

• Production: Primary fermenters, including Bifidobacterium and Bacteroides, break down non-digestible carbohydrates into pyruvate. Through pathways like the "bifid shunt," these bacteria convert pyruvate into acetyl-CoA and ultimately acetate.
• Cross-feeding: Acetate acts as a fundamental substrate for secondary fermenters. The majority of butyrate-producing bacteria, such as Faecalibacterium prausnitzii and Roseburia species, lack the enzymes for de novo butyrate synthesis and instead rely on the butyryl-CoA:acetate CoA-transferase (But) pathway.
• Carbon conversion: Metabolic tracing using 13C-labeled isotopes shows that external acetate can provide up to 85–90% of the carbon required for butyrate production by these key species. This "upcycling" of acetate into butyrate is essential for maintaining the health of the intestinal lining (colonocytes).

Bottom line

Acetate is the primary end-product of colonic fermentation and acts as a requisite fuel source for butyrate-producing bacteria. This microbial cross-feeding is a cornerstone of gut homeostasis, transforming simple fermentation products into butyrate to support gut barrier function.